It seems like there's a fresh reason to be even more bullish about the stock every single week. This past week was no exception to the trend. Here's why. Lilly's medicines Zepbound and Mounjaro ...
Still, it's hard to deny that Eli Lilly's stock keeps getting sweeter as it invests more and more work into understanding the full capabilities of its own medicine. There is no chance that this is ...